{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-18T12:20:17.022035+00:00",
  "news": [
    {
      "title": "Amgen, AZ's Tezspire gains 2nd FDA nod, upping the ante in its battle with Dupixent - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPVEhJTWc3S29XcUhkWndrSEQtQURwZXJhVlljMGNHcnVCNVAzczF1a3hSOU9kMzJRdUUxT0E0RWtEZnBWYnl1cG1CUHg5LVFOeVJ1czNLTzI5T3E2MmV6YzFYS01SSDhVTGxOVEI3c09CZXFUaXBISnpoYXFwTHFwZl9DelFEVU5XRlJQSnZicGlvUVZoRFNRcEpVQVlJYXZfUk9ydGx6bw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxPVEhJTWc3S29XcUhkWndrSEQtQURwZXJhVlljMGNHcnVCNVAzczF1a3hSOU9kMzJRdUUxT0E0RWtEZnBWYnl1cG1CUHg5LVFOeVJ1czNLTzI5T3E2MmV6YzFYS01SSDhVTGxOVEI3c09CZXFUaXBISnpoYXFwTHFwZl9DelFEVU5XRlJQSnZicGlvUVZoRFNRcEpVQVlJYXZfUk9ydGx6bw?oc=5\" target=\"_blank\">Amgen, AZ's Tezspire gains 2nd FDA nod, upping the ante in its battle with Dupixent</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-10-17T21:12:56+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5\" target=\"_blank\">US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-17T21:45:34+00:00",
      "source": "Reuters"
    },
    {
      "title": "The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOSXRWd0hEb3NGM081Vkp0SUNhSlNyYnJ1YjB0OVA1UXVsckhad1R6X1FrMVBPQ2dyemdMd3d5ekFKTUN4UjNmUkRDYVpzU0lSa0FyTkpuZHdHRmE2Ujd5aTctOFZNZzZxMDJZLWFVY2tndEEyNEJMaHJnOEpsOGdRUTMyTjVvZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxOSXRWd0hEb3NGM081Vkp0SUNhSlNyYnJ1YjB0OVA1UXVsckhad1R6X1FrMVBPQ2dyemdMd3d5ekFKTUN4UjNmUkRDYVpzU0lSa0FyTkpuZHdHRmE2Ujd5aTctOFZNZzZxMDJZLWFVY2tndEEyNEJMaHJnOEpsOGdRUTMyTjVvZw?oc=5\" target=\"_blank\">The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-17T10:22:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "The exodus from FDA’s upper ranks goes on - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNTk9xbkU5ZDFHVzVweGNjLWxWNGpINUFReENNbHpzdnhEZ0ZtcDlEMGZhZ2J1YS1TZEFvUk41RVNNZ1daOVhrWjg3ckhYV1NvRnZ0QTRZVG9KSWRScC1YMXVGeFpydDNJTHlqYlMteXFoOWZBeEI1RHZDTGJxd29FdHFqNkhCREU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxNTk9xbkU5ZDFHVzVweGNjLWxWNGpINUFReENNbHpzdnhEZ0ZtcDlEMGZhZ2J1YS1TZEFvUk41RVNNZ1daOVhrWjg3ckhYV1NvRnZ0QTRZVG9KSWRScC1YMXVGeFpydDNJTHlqYlMteXFoOWZBeEI1RHZDTGJxd29FdHFqNkhCREU?oc=5\" target=\"_blank\">The exodus from FDA’s upper ranks goes on</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-10-15T14:08:29+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Amgen, AstraZeneca announce FDA approval of Tezspire - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOa21HNU9saWxWMzdWVVJMSENlZFZ5anpSSm1PbWlmUkFER2MtckNjTVdaZ2tjeFExNWtDUC1qZF91X0hlZGtleGdjQ3UyR2NIRl9tWEhaTV9rQmNwaUZzM2pISUlGQ0c3ZGxEaV96MWR1ckVDQ2NRd2FMa1RhQmg0TS1rWGRDQkFEemFWLWJPV1JLZzJuLWhKTTJ4Q1I?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAFBVV95cUxOa21HNU9saWxWMzdWVVJMSENlZFZ5anpSSm1PbWlmUkFER2MtckNjTVdaZ2tjeFExNWtDUC1qZF91X0hlZGtleGdjQ3UyR2NIRl9tWEhaTV9rQmNwaUZzM2pISUlGQ0c3ZGxEaV96MWR1ckVDQ2NRd2FMa1RhQmg0TS1rWGRDQkFEemFWLWJPV1JLZzJuLWhKTTJ4Q1I?oc=5\" target=\"_blank\">Amgen, AstraZeneca announce FDA approval of Tezspire</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-17T20:10:10+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts - The Wall Street Journal",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "The Wall Street Journal"
    },
    {
      "title": "AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5\" target=\"_blank\">AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-09-26T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen to sell cholesterol drug at 60% discount to cash-paying US patients - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQY093WGV4Y3o1SmQ5TElWbXNtbUxhYUgyLTNNXzdnTUM4dEphOVZ1ZkNieUNlbGx0SmtNbzRpaWVRY1VnVFpld2RVMU5Xc0E1WjJ6RlVCeDkwQ25kOVlMekI5MGlNaW5UZUN0dVdKWWFfQ0ExMjJIUEIwakxQckd1eFc4YzROWUxwZ1h6T0RsdXFGTXNIQTdXSk1FWUwxOVZkTkdmdW53TlRZdGZMRDE1eHB1MVNoZzMzUExrQ1UxRTJGRGw1dF84V200VQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxQY093WGV4Y3o1SmQ5TElWbXNtbUxhYUgyLTNNXzdnTUM4dEphOVZ1ZkNieUNlbGx0SmtNbzRpaWVRY1VnVFpld2RVMU5Xc0E1WjJ6RlVCeDkwQ25kOVlMekI5MGlNaW5UZUN0dVdKWWFfQ0ExMjJIUEIwakxQckd1eFc4YzROWUxwZ1h6T0RsdXFGTXNIQTdXSk1FWUwxOVZkTkdmdW53TlRZdGZMRDE1eHB1MVNoZzMzUExrQ1UxRTJGRGw1dF84V200VQ?oc=5\" target=\"_blank\">Amgen to sell cholesterol drug at 60% discount to cash-paying US patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T17:18:39+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "$239 monthly price: Amgen's AmgenNow offers Repatha nearly 60% below U.S. list, open to all - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1WTVRhblA1c1M1Z1l1R0U4MWRWbFlIT2xGTE5ZR2I0ZEdWSTdCQzE2OERkb2lCaVROYy15Rk9hZ29BRFM2NXRyRHloWERVRkU5UmxIM3NjTmJxZ285bmZUbDEyNmduMmFUcW9waC1DckxweUZMMGg5ZlFUUDdiNkE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMif0FVX3lxTE1WTVRhblA1c1M1Z1l1R0U4MWRWbFlIT2xGTE5ZR2I0ZEdWSTdCQzE2OERkb2lCaVROYy15Rk9hZ29BRFM2NXRyRHloWERVRkU5UmxIM3NjTmJxZ285bmZUbDEyNmduMmFUcW9waC1DckxweUZMMGg5ZlFUUDdiNkE?oc=5\" target=\"_blank\">$239 monthly price: Amgen's AmgenNow offers Repatha nearly 60% below U.S. list, open to all</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-17",
      "close": 298.80999755859375
    },
    "history": [
      {
        "date": "2025-10-09",
        "close": 295.42999267578125
      },
      {
        "date": "2025-10-10",
        "close": 290.1300048828125
      },
      {
        "date": "2025-10-13",
        "close": 292.3999938964844
      },
      {
        "date": "2025-10-14",
        "close": 293.8500061035156
      },
      {
        "date": "2025-10-15",
        "close": 297.32000732421875
      },
      {
        "date": "2025-10-16",
        "close": 295.80999755859375
      },
      {
        "date": "2025-10-17",
        "close": 298.80999755859375
      }
    ],
    "name": "Amgen Inc."
  }
}